Theobromine
Theobromine, the main methylxanthine in cocoa, is marketed as a smooth, jitter-free caffeine alternative. Controlled trials show it does raise HDL cholesterol at drug-like doses, but the evidence for energy, focus and vascular benefit is weak to outright negative — and pre-workout doses are far below anything tested.
What the science says
- Raises HDL cholesterol at 850 mg/day Moderate evidence
A 152-person, 4-week double-blind randomized factorial trial found pure theobromine raised HDL cholesterol by 0.16 mmol/L (about 6 mg/dL, p < 0.0001) and apolipoprotein A-I, while modestly lowering apoB and LDL (p < 0.02); cocoa flavanols had no independent effect, suggesting theobromine is the component behind cocoa's HDL signal. Important caveat: raising HDL is a surrogate marker, and several drugs that raised HDL substantially failed to reduce cardiovascular events.
- Does not improve vascular function Limited evidence
A separate randomized trial in overweight and obese subjects found theobromine consumption did not improve fasting or postprandial vascular function — a direct negative result for the "cocoa for blood vessels" story when the flavanols are removed.
- The stimulant and focus claims are largely unsupported at label doses Limited evidence
Theobromine is a far weaker adenosine receptor antagonist than caffeine, with a long half-life of roughly 7-10 hours. Acute human studies at 250-1000 mg have generally shown little to no improvement in alertness or cognitive performance, and the higher doses tended to produce nausea and headache rather than energy. Pre-workouts typically add 100-200 mg — below the dose range that failed to show cognitive effects, let alone one that showed them.
Dosage & safety
Scientific references
Where to buy
View on iHerbReferral link — this site may earn a commission on purchases.
Related in Heart & metabolic
- Vitamin B3 (Niacin) Limited evidence
- Vitamin K2 (MK-7) Limited evidence
- Chromium Limited evidence
- Potassium Strong evidence
- Vanadium Limited evidence
- L-Arginine Moderate evidence